Biomedical Engineering Reference
In-Depth Information
145. Mayahara H, Ito T, Nagai H, Miyajima H, Tsukuda R,
Taketomi S, Mizoguchi J, Kato K (1993) In vivo
stimulation of endosteal bone formation by basic
fi broblast growth factor in rats. Growth Factors
9:73-80.
146. Maye P, Zheng J, Li L, Wu D (2004) Multiple mecha-
nisms for Wnt11-mediated repression of the canoni-
cal Wnt signaling pathway. J Biol Chem 279:24659-
24665.
147. Mayr-Wohlfart U, Waltenberger J, Hausser H, Kessler
S, Gunther KP, Dehio C, Puhl W, Brenner RE (2002)
Vascular endothelial growth factor stimulates che-
motactic migration of primary human osteoblasts.
Bone 30:472-477.
148. Minina E, Kreschel C, Naski MC, Ornitz DM, Vort-
kamp A (2002) Interaction of FGF, Ihh/Pthlh, and
BMP signaling integrates chondrocyte proliferation
and hypertrophic differentiation. Dev Cell 3:439-
449.
149. Miyazono K (2002) Bone morphogenetic protein
receptors and actions (Chapter 51). In: Bilezikian JP,
Raisz LG, Rodan GA, eds. Principles of Bone Biology.
2nd edition. San Diego: Academic Press, pp 929-
942.
150. Miyazono Y (1999) Signal transduction by bone mor-
phogenetic protein receptors: functional roles of
Smad proteins. Bone 25:91-93.
151. Mosekilde L, Sogaard CH, Danielsen CC, Torring O
(1991) The anabolic effects of human parathyroid
hormone (hPTH) on rat vertebral body mass are also
refl ected in the quality of bone, assessed by biome-
chanical testing: a comparison study between hPTH-
(1-34) and hPTH-(1-84). Endocrinology 129:421-
428.
152. Murakami S, Balmes G, McKinney S, Zhang Z,
Givol D, de Crombrugghe B (2004) Constitutive
activation of MEK1 in chondrocytes causes Stat1-
independent achondroplasia-like dwarfi sm and
rescues the Fgfr3-defi cient mouse phenotype. Genes
Dev 18:290-305.
153. Nagata S (1997) Apoptosis by death factor. Cell
88:356-365.
154. Nakahara H, Bruder SP, Haynesworth SE, Holecek JJ,
Baber MA, Goldberg VM, Caplan AI (1990) Bone and
cartilage formation in diffusion chambers by subcul-
tured cells derived from the periosteum. Bone
11:181-188.
155. Nakajima A, Shimoji N, Shiomi K, Shimizu S,
Moriya H, Einhorn TA, Yamazaki M (2002) Mecha-
nisms for the enhancement of fracture healing in rats
treated with intermittent low-dose human parathy-
roid hormone (1-34). J Bone Miner Res 17:2038-
2047.
156. Nakamura T, Hanada K, Tamura M, Shibanushi T,
Nigi H, Tagawa M, Fukumoto S, Matsumoto T (1995)
Stimulation of endosteal bone formation by systemic
injections of recombinant basic fi broblast growth
factor in rats. Endocrinology 136:1276-1284.
157. Nakase T, Nomura S, Yoshikawa H, Hashimoto J,
Hirota S, Kitamura Y, Oikawa S, Ono K, Takaoka K
(1994) Transient and localized expression of bone
morphogenetic protein 4 messenger RNA during
fracture healing. J Bone Miner Res 9:651-659.
158. Nanes MS (2003) Tumor necrosis factor-alpha:
molecular and cellular mechanisms in skeletal
pathology. Gene 321:1-15.
159. Neer RM, Arnaud CD, Zanchetta JR, Prince R,
Gaich GA, Reginster JY, Hodsman AB, Eriksen EF,
Ish-Shalom S, Genant HK, Wang O, Mitlak BH
(2001) Effect of parathyroid hormone (1-34) on frac-
tures and bone mineral density in postmenopausal
women with osteoporosis. N Engl J Med 344:1434-
14 41.
160. Nickel J, Dreyer MK, Kirsch T, Sebald W (2001) The
crystal structure of the BMP-2:BMPR-IA complex
and the generation of BMP-2 antagonists. J Bone
Joint Surg Am 83A(Suppl 1):S7-S14.
161. Nishioka K, Dennis JE, Gao J, Goldberg VM, Caplan
AI (2005) Sustained Wnt protein expression in chon-
dral constructs from mesenchymal stem cells. J Cell
Physiol 203:6-14.
162. Nusslein-Volhard C, Wieschaus E (1980) Mutations
affecting segment number and polarity in Drosoph-
ila. Nature 287:795-801.
163. Olsen NJ, Stein CM (2004) New drugs for rheumatoid
arthritis. N Engl J Med 350:2167-2179.
164. Ornitz DM, Itoh N (2001) Fibroblast growth factors.
Genome Biol 2:REVIEWS3005.
165. Ornitz DM, Marie PJ (2002) FGF signaling pathways
in endochondral and intramembranous bone devel-
opment and human genetic disease. Genes Dev
16:14 46 -1465.
166. Ozkaynak E, Rueger DC, Drier EA, Corbett C, Ridge
RJ, Sampath TK, Oppermann H (1990) OP-1 cDNA
encodes an osteogenic protein in the TFG-beta
family. EMBO J 9:2085-2093.
167. Park YS, Kim NH, Jo I (2003) Hypoxia and vascular
endothelial growth factor acutely up-regulate angio-
poietin-1 and Tie2 mR NA i n bov i ne ret i na l peric y tes.
Microvasc Res 65:125-131.
168. Parr BA, McMahon AP (1995) Dorsalizing signal
Wnt-7a required for normal polarity of D-V and A-P
axes of mouse limb. Nature 374:350-353.
169. Podbesek R, Edouard C, Meunier PJ, Parsons JA,
Reeve J, Stevenson RW, Zanelli JM (1983) Effects of
two treatment regimes with synthetic human para-
thyroid hormone fragment on bone formation and
the tissue balance of trabecular bone in greyhounds.
Endocrinology 112:1000-1006.
170. Praemer AP, Furner S, Rice DP (1992) Musculoskele-
tal Conditions in the United States. Park Ridge:
American Academy of Orthopaedic Surgeons.
171. Ramsauer M, D'Amore PA (2002) Getting Tie(2)d up
in angiogenesis. J Clin Invest 110:1615-1617.
172. Reddi AH (2001) Bone morphogenetic proteins: from
basic science to clinical applications. J Bone Joint
Surg Am 83A:S1-S6.
173. Reimold AM, Grusby MJ, Kosaras B, Fries JW, Mori
R, Maniwa S, Clauss IM, Collins T, Sidman RL, Glim-
cher MJ, Glimcher LH (1996) Chondrodysplasia and
neurological abnormalities in ATF-2-defi cient mice.
Nature 379:262-265.
174. Roach HI, Erenpreisa J, Aigner T (1995) Osteogenic
differentiation of hypertrophic chondrocytes
involves asymmetric cell division. J Cell Biol 131:
483-494.
175. Roodman GD (2002) Role of the bone marrow micro-
environment in multiple myeloma. J Bone Miner Res
17:1921-1925.
176. Rosen V, Thies RS (1992) The BMP proteins in
bone formation and repair. Trends Genet 8:97-
102.
